Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Ketamine for Postoperative Mood in Depressed Patients
NCT02422303Terminated
- Sponsor
- UT Health San Antonio
- Start
- Dec 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of ketamine in major depressive disorder (MDD) (2 arms), sponsored by UT Health San Antonio. Primary endpoint: Depression Score Using Goldberg Depression Screening Test at 1 week. Started Dec 2015; status: terminated.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02422303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422303.